:::

詳目顯示

回上一頁
題名:巴金森失智症與路易氏體失智症
書刊名:應用心理研究
作者:黃楚雲黃錦章
作者(外文):Huang, Chu-yunHuang, Chin-chang
出版日期:2012
卷期:55
頁次:頁59-98
主題關鍵詞:巴金森失智症路易氏體失智症神經影像病理生物標記診斷治療Parkinson's disease with dementiaDementia with Lewy bodiesNeuroimagesPathologyBiomarkersDiagnosisTreatment
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(2) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:2
  • 共同引用共同引用:0
  • 點閱點閱:69
期刊論文
1.Aarsland, D.、Andersen, K.、Larsen, J. P.、Lolk, A.、Kragh-Sørensen, P.(2003)。Prevalence and characteristics of dementia in Parkinson disease: An 8 year prospective study。Archives of Neurology,60(3),387-392。  new window
2.Aarsland, D.、Andersen, K.、Larsen, J. P.、Lolk, A.、Nielsen, H.、Kragh-Sørensen, P.(2001)。Risk of dementia in Parkinson’s disease: A community-based, prospective study。Neurology,56(6),730-736。  new window
3.Aarsland, D.、Andersen, K.、Larsen, J. P.、Perry, R.、Wentzel-Larsen, T.、Lolk, A.、Kragh-Sørensen, P.(2004)。The rate of cognitive decline in Parkinson disease。Archives of Neurology,61(12),1906-1911。  new window
4.Aarsland, D.、Ballard, C. G.、Halliday, G.(2004)。Are Parkinson’s disease with dementia and dementia with Lewy bodies the same entity?。Journal Geriatric Psychiatry Neurology,17(3),137-145。  new window
5.Aarsland, D.、Larsen, J. P.、Cummins, J. L.、Laake, K.(1999)。Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: A community-based study。Archives of Neurology,56(5),595-601。  new window
6.Aarsland, D.、Perry, R.、Larsen, J. P.、McKeith, I. G.、O'Brien, J. T.、Perry, E. K.、Ballard, C. G.(2005)。Neuroleptic sensitivity in Parkinson’s disease and parkinsonian dementias。Journal Clinical Psychiatry,66(5),633-637。  new window
7.Ballard, C. G.、Aarsland, D.、McKeith, I.、O'Brien, J.、Gray, A.、Cormack, F.、Tovee, M.(2002)。Fluctuations in attention: PD dementia vs. DLB with Parkinsonism。Neurology,59(11),1714-1720。  new window
8.Barber, R.、Ballard, C.、McKeith, I. G.、Gholkar, A.、O'Brien, J. T.(2000)。MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia。Neurology,54(6),1304-1309。  new window
9.Barber, R.、Gholkar, A.、Scheltens, P.、Ballard, C.、McKeith, I. G.、O'Brien, J. T.(1999)。Medial temporal lobe atrophy on MRI in dementia with Lewy bodies。Neurology,52(6),1153-1158。  new window
10.Barber, R.、Scheltens, P.、Gholkar, A.、Ballard, C.、McKeith, I.、Ince, P.(1999)。White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging。Journal of Neurology Neurosurgery and Psychiatry,67(1),66-72。  new window
11.Barker, W. W.、Kashuba, A.、Luis, M.、Harwood, D. G.、Loewenstein, D.、Duara, R.(2002)。Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank。Alzheimer Disease & Associated Disorders,16(4),203-212。  new window
12.Boeve, B. F.、Ferman, T. J.、Silber, M. H.、Ferman, T. J.(2003)。Sleep disturbances in dementia with Lewy bodies involve more than REM sleep behavior disorder。Neurology,60,A79。  new window
13.Boeve, B. F., Silber, M. H., & Ferman, T. J.(20040901)。REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies。Journal Geriatric Psychiatry Neurology,17(3),146-157。  new window
14.Boeve, B. F.、Silber, M. H.、Parisi, J. E.、Dickson, D. W.、Ferman, T. J.、Benarroch, E. E.、Mahowald, M. W.(2003)。Synucleinopathy pathology and REM sleep behavior disorder plus dementia or Parkinsonism。Neurology,61(1),40-45。  new window
15.Bonini, N. M.、Giasson, B. I.(2005)。Snaring the function of alpha-synuclein。Cell,123(3),359-361。  new window
16.Braak, H.、Del Tredici, K.、Rub, U.、De Vos, R. A.、Jansen Steur, E. N.、Braak, E.(2003)。Staging of brain pathology related to sporadic Parkinson’s disease。Neurobiology Aging,24(2),197-211。  new window
17.Braak, H.、Rub, U.、Jansen Steur, E. N.、Del Tredici, K.、De Vos, R. A.(2005)。Cognitive status correlates with neuropathologic stage in Parkinson’s disease。Neurology,64(8),1404-1410。  new window
18.Bradshaw, J. M.、Saling, M.、Anderson, V.、Hopwood, M.、Brodtmann, A.(2006)。Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer’s type and controls。Journal of Neurology Neurosurgery and Psychiatry,77(10),1129-1135。  new window
19.Burn, D. J.、Rowan, E. N.、Minnett, T.、Sanders, J.、Myint, P.、Richardson, J.、McKeith, I. G.(2003)。Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study。Movement Disorder,18(8),884-889。  new window
20.Burn, D. J.(2006)。Cortical Lewy body disease and Parkinson’s disease dementia。Current Opinion Neurology,19(6),572-579。  new window
21.Cahn-Weiner, D. A.、Williams, K.、Grace J.、Tremont, G.、Weatervelt, H.、Stern, R. A.(2003)。Discrimination of dementia with Lewy bodies from Alzheimer’s disease and Parkinson’s disease using the clook drawing test。Cognition Behavior Neurology,16(2),85-92。  new window
22.Caparros-Lefebvre, D.、Pechevx, N.、Petit, V.、Duhamel, A.、Petit, H.(1995)。Which factors predict cognitive decline in Parkinson’s disease?。Journal of Neurology Neurosurgery and Psychiatry,58(1),51-55。  new window
23.Chandra, S.、Gallardo, G.、Fernandez-Chacon, R.、Schlüter, O. M.、Südhof, T. C.(2005)。A lpha-synuclein cooperates with CSP alpha in preventing neurodegeneration。Cell,123(3),383-396。  new window
24.Chang, C. C.、Liu, J. S.、Chang, Y. Y.、Chang, W. N.、Chen, S. S.、Lee, C. H.(2008)。(99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: A correlation with neuropsychological tests。European Journal of Neurology,15(1),61-65。  new window
25.Chiu, M. J.,、Yi, P. K.、Yi, P. K.、Chen, T. F.、Hua, M. S.、Tang, L. Y.(2006)。Behavioral and psychologic symptoms in different types of dementia。Journal of Formosan Medical Association,105(7),556-562。  new window
26.Chui, H. C.、Mortimer, J.、A., Slager, U.、Zarow, C.、Bondareff, W.、Webster, D. D.(1986)。Pathologic correlates of dementia in Parkinson’s disease。Archives of Neurology,43(10),991-995。  new window
27.Cole, N. B.、Murphy, D. D.、Grider, T.、Rueter, S.、Brasaemle, D.、Nussbaum, R. L.(2002)。Lipid droplet binding and oligomerization properties of the Parkinson’s disease protein alpha-synuclein。Journal of Biological Chemistry,277(8),6344-6352。  new window
28.Collerton, D.、Burn, D.、McKeith, I.、Obrien, J.(2003)。Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia。Dementia Geriatric Cognitive Disorder,16(4),229-237。  new window
29.Costa, A.、Pappe, A.、Dell’Agnello, G.、Carlesimo, G. A.、Murri, L.、Bonuccelli, U.、Caltagirone, C.(2003)。Dopaminergic modulation of visual-spatial working memory in Parkinson’s disease。Dementia Geriatric Cognitive Disorder,15(2),55-66。  new window
30.Cousins, D. A.、Burton, E. J.、Burn, D.、Gholkar, A.、McKeith, I. G.,(2003)。Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease: An MRI study。An MRI study. Neurology,61(9),1191-1195。  new window
31.Donnemiller, E.、Heilmann, J.、Wenning, G. K.、Berger, W.、Decristoforo, C.、Moncayo, R.、Ransmayr, G.(1997)。Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-bata-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease。European Journal Nuclear Medicine,24(3),320-325。  new window
32.Dubois, B.、Burn, D.、Goetz, C.,、Aarsland, D.、Brown, R. G.、Broe, G. A.、Emre, M.(2007)。Diagnostic procedures for Parkinson’s disease dementia: Recommendations for the movement disorder society take force。Movement Disorder,22(16),2314-2324。  new window
33.Edwards, K.、Royall, D.、Hershey, L.、Lichter, P. Hake, A.、Farlow, M.、Johnson, S.(2007)。Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study。Dementia Geriatric Cognitive Disorder,23(6),401-405。  new window
34.Emre, M.、Aarsland, D.、Brown, R.、Burn, D. J.、Duyckaerts, C.、Mizuno, Y.、Dubois, B.(2007)。Clinical diagnostic criteria for dementia associated with Parkinson’s disease。Movement disorder,22(12),1689-1707。  new window
35.Ferman, T. J.、Smith, G. E.、Boeve, B. F.、Ivnik, R. J.、Petersen, R. C.、Knopman, D.、Dickson, D. W.(2004)。DLB fluctuations: Specific features that reliably differentiate DLB from AD and normal aging。Neurology,62(2),181-187。  new window
36.Fernandez, H. H.、Trieschmann, M. E.、Burke, M. A.、Friedman, J. H.(2002)。Quetiapine for psychosis in Parkinson’s disease versus dementia with Lewy bodies。Journal Clinical Psychiatry,63(6),513-515。  new window
37.Fernandez, H. H.、Trieschmann, M. E.、Burke, M. A.、Jacques, C.、Friedman, J. H.(2003)。Long-term outcome of quetiapine use for psychosis among Parkinsonian patients。Movement Disorder,18(5),510-514。  new window
38.Forsberg, A.、Engler, H.、Almkvist, O.、Blomquist, G.、Hagman, G.、Wall, A.、Nordberg, A.(2008)。PET imaging of amyloid deposition in patients with mild cognitive impairment。Neurobiology Aging,29(10),1456-1465。  new window
39.Galvin, J. E.(2006)。Cognitive change in Parkinson disease。Alzheimer Disease Association Disorder,20(4),302-310。  new window
40.Galvin, J. E.、Lee, V. CM.、Trojanowski, J. Q.(2001)。Synucleinopathies: Clinical and pathological implications。Archives Neurology,58(2),186-190。  new window
41.Galvin, J. E.、Pollack, J.、Morris, J. C.(2006)。Clinical phenotype of Parkinson disease dementia。Neurology,67(9),1605-1611。  new window
42.Gaspar, P.、Gray, F.(1984)。Dementia in idiopathic Parkinson’s disease: A neuropathological study of 32 cases。Acta Neuropathological,64(1),43-52。  new window
43.George, J. M.、Jin, H.、Woods, W. S.、Clayton, D. F.(1995)。Characterization of a novel protein regulated during the critical period for song learning in the zebra finch。Neuron,15(2),361-372。  new window
44.Gjerstad, M. D.、Aarsland, D.、Larsen, J. P.(2002)。Development of daytime somnolence overtime in Parkinson’s disease。Neurology,58(10),1544-1546。  new window
45.Han, H.、Weinreb, P. H.、Lansbury, P. T.(1995)。The core A lzheimer’s peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: Is NA C a common trigger or target in neurodegenerative disease?。Chemical Biology,2(3),163-169。  new window
46.Harding, A. J.、Broe, G. A.、Halliday, G. M.(2002)。Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe。Brain,125(Pt2),391-403。  new window
47.Henderson, R.、Kurlan, R.、Kersun, J. M.、Como, P. G.(1992)。Preliminary examination of the comorbidity of anxiety and depression in Parkinson’s disease。Journal Neuropsychiatry Clinical Neuroscience,4(3),257-264。  new window
48.Higuchi, M.、Tashiro, M.、Arai, H.、Okamura, N.、Hara, S.、Higuchi, S.、Sasaki, H.(2000)。Glucose hypometabolis m and neuropathological correlates in brains of dementia with Lewy bodies。Experimental Neurology,162(2),247-256。  new window
49.Hsiao, I. -T.、Huang, C. -C.、Hsieh, C. -J.、Hsu, W. -C.、Wey, S. -P.、Yen, T. -C.、Lin, K. -J.(2012)。Correlation of early-phase F-18 Florbetapir (A V-45/Amyvid) PET images to FDG images: Preliminary studies。European Journal of nuclear medicine and molecular imaging,39(4),613-620。  new window
50.Hu, X. S.、Okamura, N.、Arai, H.、Higuchi, M.、Matsui, T.、Tashiro, M.、Sasaki, H.(2000)。18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies。Neurology,55(10),1575-1577。  new window
51.Hughes, T. A.、Ross, H. F.、Musa, S.、Bhattacherjee, S.、Nathan, R. N.、Mindham, R. H.、Spokes, E. G.(2000)。A 10-year study of the incidence and factors predicting dementia in Parkinson’s disease。Neurology,54(8),1596-1602。  new window
52.Jakes, R.、Spillantini, M. G.、Goedert, M.(1994)。Identification of two distinct synucleins from human brain。FEBS Letters,345(1),27-32。  new window
53.Janvin, C. C.、Larsen, J. P.、Salmon, D. P.、Galasko, D.、Hugdahl, K.、Aarsland, D.(2006)。Cognitive profiles of individual patients with Parkinson’s disease and dementia: Comparison with dementia with Lewy bodies and Alzheimer’s disease。Movement Disorder,21(3),337-342。  new window
54.Ji, H.、Liu, Y. E.、Jia, T.、Wang, M.、Liu, J.、Xiao, G.、Shi, Y. E.(1997)。Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing。Cancer Research,57(4),759-764。  new window
55.Johnson, D. K.、Morris, J. C.、Galvin, J. E.(2005)。Verbal and visuospatial deficits in dementia with Lewy bodies。Neurology,65(8),1232-1238。  new window
56.Kenny, R. A.、Kalaria, R.、Ballard, C.(200211)。Neurocardiovascular instability in cognitive impairment and dementia。Annals of the New York Academy Sciences,977,183-195。  new window
57.Kenny, R. A.、Shaw, F. E.、O’Brien, J. T.、Scheltens, P. H.、Kalaria, R.、Ballard, C.(2004)。Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions。Journal of Neurology Neurosurgery and Psychiatry,75(7),966-971。  new window
58.Klatka, L. A.、Louis, E. D.、Schiffer, R. B.(1996)。Psychiatric features in diffuse Lewy body disease: A clinicopathologic study using Alzheimer’s disease and Parkinson’s disease comparison groups。Neurology,47(5),1148-1152。  new window
59.Klunk, W. E.、Engler, H.、Nordberg, A.、Wang, Y.、Blomqvist, G.、Holt, D. P.、Långström, B.(2004)。Imaging brain amyloid in A lzheimer’s disease with Pittsburgh compound-β。Annals of Neurology,55(3),306-319。  new window
60.Kosaka, K.(1990)。Diffuse Lewy body disease in Japan。Journal of Neurology,237(3),197-204。  new window
61.Kosaka, K.、Matsushita, M.、Oyanagi, S.、Mehraein, P.(1980)。A clinicopathological study of the Lewy body disease。Psychiatric Neurology Japanica,82(5),292-311。  new window
62.Kovari, E.、Gold, G.、Herrmann, F. R.、Canuto, A.、Hof, P. R.、Bouras, C.、Giannakopoulos, P.(2003)。Lewy body densities in the entorhinal and anterior cingulated cortex predict cognitive deficits in Parkinson’s disease。Acta Neuropathologica,106(1),83-88。  new window
63.Kuzis, G.、Sabe, L.、Tiberti, C.、Leiguarda, R.、Starkstein, S. E.(1997)。Cognitive functions in major depression and Parkinson’s disease。Archives of Neurology,54(8),982-986。  new window
64.Lees, A. J.、Smith, E.(1983)。Cognitive deficits in the early stages of Parkinson's disease。Brain,106(part 2),257-270。  new window
65.Lavedan, C.、Leroy, E.、Dehejia, A.、Buchholtz, S.、Dutra, A.、Nussbaum, R. L.、Polymeropoulos, M. H.(1998)。Identification, localization and characterization of the human gamma-synuclein gene。Human Genetics,103(1),106-112。  new window
66.Lee, W. -J.、Tsai, C. -F.、Wang, S. -J.、Gauthier, Serge(201212)。The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson’s disease dementia。International Psychogeriatrry,24(12),1980-1987。  new window
67.Levin, B. E.、Llabre, M. M.、Weiner, W. J.(1989)。Cognitive impairments associated with early Parkinson's disease。Neurology,39(4),557-561。  new window
68.Lin, K. J.、Hsu, W. C.、Hsiao, I. T.、Wey, S. P.、Jin, L. W.、Skovronsky, D.、Kung, M. P.(2010)。Whole body biodistribution and brain PET imaging with [18F] AV-45, a novel amyloid imaging agent-a pilot study。Nuclear Medicine Biology,37(4),497-508。  new window
69.Lippa, C. F.、Duda, J. E.、Grossman, M.、Hurtig, H. I.、Aarsland, D.、Boeve, B. F.、Wszolek, Z. K.(2007)。DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers。Neurology,68(11),812-819。  new window
70.Litvan, I.、Goldman, J. G.、Tröster, A. I.、Schmand, B. A.、Weintraub, D.、Petersen, R. C.、Emre, M.(201203)。Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines。Mov Disord,27(3),349-356。  new window
71.Liu, C. -K.、Lai, C. -L.、Tai, C. -T.、Lin, R. -T.、Yen, Y. -Y.、Howng, S. -L.(1998)。Incidence and subtypes of dementia in southern Taiwan impact of socio-demographic factors。Neurology,50(6),1572-1579。  new window
72.Louis, E. D.、Klatka, L. A.、Liu, Y.、Fahn, S.(1997)。Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease。Neurology,48(2),376-380。  new window
73.Martí, M. J.、Tolosa, E.、Campdelacreu, J.(2003)。Clinical overview of the synucleinopathies。Movement Disorder,18(Suppl 6),S21-S27。  new window
74.Mathis, C. A.、Backskai, B. J.、Kajdasz, S. T.、McLellan, M. E.、Frosch, M. P.、Hyman, B. T.、Klunk, W. E.(2002)。A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain。Bioorganic&Medicinal Chemistry Letters,12(3),295-298。  new window
75.Matsui, H.、Udaka, F.、Miyoshi, T.、Hara, N.、Tamura, A.、Oda, M.、Kameyama, M.(2005)。N-isopropyl-p-123I iodoamphetamine single photon emission computed tomography study of Parkinson's disease with dementia。International Medicine,44(10),1046-1050。  new window
76.McKeith, I. G.(2000)。Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia。Neurologic Clinic,18(4),865-902。  new window
77.McKeith, I. G.(2007)。Dementia with Lewy Bodies and Parkinson’s disease with dementia: Where two world collide。Practical Neurology,7(6),374-382。  new window
78.McKeith, I.、Del Ser, T.、Spano, P.、Emre, M.、Wesnes, K.、Anand, R.、Spiegel, R.(2000)。Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study。Lancet,356(9247),2031-2036。  new window
79.McKeith, I.、Mintzer, J.、Aarsland, D.、Burn, D.、Chiu, H.、Cohen-Wansfield, J.、Reid, W.(2004)。Dementia with Lewy bodies。Lancet Neurology,3(1),19-28。  new window
80.McKeith, I. G.、Ballard, C. G.、Perry, R. H.、Ince, P. G.、O'Brien, J. T.、Neill, D.、Perry, E. K.(2000)。Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies。Neurology,54(5),1050-1058。  new window
81.McKeith, I. G.、Dickson, D. W.、Lowe, J.、Emre, M.、O'Brien, J. T.、Feldman, H.、Yamada, M.(2005)。Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium。Neurology,65(12),1863-1872。  new window
82.McKeith, I. G.、Fairbairn, A. F.、Perry, R. H.,、Thompson, P.(1994)。The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT)。British Journal of Psychiatry,165(3),324-332。  new window
83.McKeith, I. G.、Galasko, D.、Kosaka, K.、Perry, E. K.、Dickson, D. W.、Hansen, L. A.、Perry, R. H.(1996)。Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop。Neurology,47(5),1113-1124。  new window
84.McKeith, I. G.、Perry, R. H.、Fairbairn, A. F.、Jabeen, S.、Perry, E. K.(1992)。Operational criteria for senile dementia of Lewy body type (SDLT)。Psychological Medicine,22(4),911-922。  new window
85.McKeith, I. G.、Wesnes, K. A.、Perry, E.、Ferrara, R.(2004)。Halluc inations predict attentional improvements with rivastigmine in dementia with lewy bodies。Dementia Geriatric Cognitive Disorder,18(1),94-100。  new window
86.Meco, G.、Bonifati, V.、Cusimano, G.、Fabrizio, E.、Vanacore, N.(1990)。Hallucinations in Parkinson disease: Neuropsychological study Ital。Journal of the Neurologic Sciences,11(4),373-379。  new window
87.Menza, M. A.、Robertson-Hoffman, D. E.、Bonapace, A. S.(1993)。Parkinson's disease and anxiety: Comorbidity with depression。Biological Psychiatry,34(7),465-470。  new window
88.Monsch, A. U.、Bondi, M. W.、Butters, N.、Salmon, D. P.、Katzman, R.、Thal, L. J.(1992)。Comparisons of verbal fluency tasks in the detection of dementia of the alzheimer type。Arch Neurol,49(12),1253-1258。  new window
89.Molloy, S.、McKeith, I. G.、O'Brien, J. T.、Burn, D. J.(2005)。The role of L-dopa in the management of dementia with Lewy bodies。Journal of Neurology Neurosurgery and Psychiatry,76(9),1200-1203。  new window
90.Mori, E.、Shimomura, T.、Fujimori, M.、Hirono, N.、Ima mura, T.、Hashimoto, M.、Hanihara, T.(2000)。Visuoperceptual impairment in dementia with Lewy bodies。Archives of Neurolgy,57(4),489-493。  new window
91.Mosimann, U. P.、Mather, G.、Wesnes, K. A.、O'Brien, J. T.、Burn, D. J.、McKeith, I. G.(2004)。Visual perception in Parkinson disease dementia and dementia with Lewy bodies。Neurology,63(11),2091-2096。  new window
92.Murphy, D. D.、Rueter, S. M.、Trojanowski, J. Q.、Lee, V. M.(2000)。Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons。Journal of the Neurologic Sciences,20(9),3214-3220。  new window
93.Ninkina, N. N.、A limova-Kost, M. V.、Paterson, J. W.、Delaney, L.、Cohen, B. B.、Imreh, S.、Buchman, V. L.(1998)。Organization, expression and polymorphis m of the human persyn gene。Human Molecular Genetics,7(9),1417-1424。  new window
94.Okereke, C. S.、Kirby, L.、Kumar, D.、Cullen, E. I.、Pratt, R. D.、Hahne, W. A.(2004)。Concurrent administration of donepezil HCl and L-dopa/carbidopa in patients with Parkinson's disease: Assessment of pharmacokinetic changes and safety following multiple oral doses。British Journal of Clinical Pharmacology,58(S1),41-49。  new window
95.Orskov, L.、Jakobsen, J.、Dupont, E.、De Fine Olivarius, B.、Christensen, N. J.(1987)。Autonomic function in parkinsonian patients relates to duration of disease。Neurology,37(7),1173-1178。  new window
96.Owen, A. M.、Roberts, A. C.、Hodges, J. R.、Summers, B. A.、Polkey, C. E.、Robbins, T. W.(1993)。Contrasting mechanis ms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease。Brain,116 (Pt5),1159-1175。  new window
97.Polymeropoulos, M. H.、Lavedan, C.、Leroy, E.、Ide, S. E.、Dehejia, A.、Dutra, A.、Nussbaum, R, L.(1997)。Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease。Science,276(5321),2045-2047。  new window
98.Price, J. C.、Kleenk, W. E.、Lopresti, B. J.、Lu, X.、Hoge, J. A.、Ziolko, S. K.、Mathis, C. A.(2005)。Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-β。Journal Cerebral Blood flow metabolism,25(11),1528-1547。  new window
99.Rahkonen, T.、Eloniemi-Sulkava, U.、Rissanen, S.、Vatanen, A.、Viramo, P.、Sulkava, R.(2003)。Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older。Neurosurgery, and Psychiatry,74(6),720-724。  new window
100.Ramakrishnan, M.、Jensen, P. H.、Marsh, D.(2003)。A lpha-synuclein association with phosphatidylglycerol probed by lipid spin labels。Biochemistry,42(44),12919-12926。  new window
101.Ridha, B. H.、Josepha, K. A.、Rossor, M. N.(2005)。Delusions and hallucinations in dementia with Lewy bodies: Worsening with memantine。Neurology,65(3),481-482。  new window
102.Rodriguez-Fernandez, A.、Gomez-Rio, M.、Carnero, C.(1998)。Regional cerebral blood flow in patients with dementia with Lewy bodies。Neurobiology Aging,19,S205。  new window
103.Rowe, C. C.、Ng, S., Ackermann, U.、Gong,S. J.、Pike, K.、Savage, G.、Villemagne, V. L.(2007)。Imaging beta-amyloid burden in aging and dementia。Neurology,68(20),1718-1725。  new window
104.Sabbagh, M. N.、Hake, A. M.、Ahmed, S.、Farlow, M. R.(2005)。The use of memantine in dementia with Lewy bodies。Journal of Alzheimer’s Disease,7(4),285-289。  new window
105.Salmon, D. P.、Galasko, D.、Hansen, L. A.、Masliah, E.、Butters, N.、Thal, L. J.、Katzman, R.(1996)。Neuropsychological deficits associated with diffuse Lewy body disease。Brain and Cognition,31(2),148-165。  new window
106.Sano, M.、Stern, Y.、W illiams, J.、Cote, L.、Rosenstein, R.、Mayeux, R.(1989)。Coexisting dementia and depression in Parkinson’s disease。Archives of Neurology,46(12),1284-1286。  new window
107.Senard, J. M.、Rai, S.、Lapeyre-Mestre, M.、Brefel, C.、Rascol, O.、Rascol, A.、Montastruc, J. L.(1997)。Prevalence of orthostatic hypotension in Parkinson’s disease。Journal of Neurology Neurosurgery and Psychiatry,63(5),584-589。  new window
108.Sharon, R.、Bar-Joseph, I.、Mirick, G. E.、Serhan, C. N.、Selkoe, D. J.(2003)。Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies。Journal of Biological Chemistry,278(50),49874-49881。  new window
109.Shimizu, S.、Hanyu, H.、Kanetaka, H.、Iwamoto, T.、Koizumi, K.、Abe, K.(2005)。Differentiation of dementia with Lewy bodies from Alzheimer’s disease using brain SPECT。Dementia Geriatric Cognitive Disorder,20(1),25-30。  new window
110.Spillantini, M. G.、Divane, A.、Goedert, M.(1995)。Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35。Genomics,27(2),379-381。  new window
111.Stevens, T.、Livingston, G.、Kitchen, G.、Manela, M.、Walker, Z.、Katona, C.(2002)。Islington study of dementia subtypes in the community。British Journal of Psychiatry,180(3),270-276。  new window
112.Tobe, T.、Nakajo, S.、Tanaka, A.、Mitoya, A.、Omata, K.、Nakaya, K.、Nakamura, Y.(1992)。Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein。Journal of Neurochemistry,59(5),1624-1629。  new window
113.Touchon, J.、Bergman, H.、Bullock, R.、Rapatz, G.、Nagel, J.、Lane, R.(2006)。Response to rivastigmine or donepezil in A lzheimer’s patients with symptoms suggestive of concomitant Lewy body pathology。Current Medical Reseach Opinion,22(1),49-59。  new window
114.Tsuboi, Y.、Dickson, D. W.(2005)。Dementia with Lewy bodies and Parkinson’s disease with dementia: Are they different。Parkinsonism and Related Disorders,11(S1),S47-S51。  new window
115.Verhoeff, N. P.、Wilson, A. A.、Takeshita, S.、Trop, L.、Hussey, D.、Singh, K.、Houle, S.(2004)。In -vivo imaging of Alzheimer’s disease beta-amyloid with〔11C〕-SB13PET。American Journal Geriatric Psychiatry,12(6),584-595。  new window
116.Walker, Z.、Graces, J.、Overshot, R.、Satarasinghe, S.、Swan, A.、Katona, C. L.、McKeith, I. G.(1999)。Olanzapine in dementia with Lewy bodies: A clinical study。International Journal of Geriatric Psychiatry,14(6),459-466。  new window
圖書
1.Parkinson, J.(1817)。An essay on the shaking palsy。London:Sherwood, Neely and Jones。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top